12
nanotimes
Companies Facts
Degeneration and general corporate purposes. ACT expects to end the year with approximately $15 mil- lion in cash and equivalents, and less than $1 million of debt. The Company recently strengthened its ba- lance sheet by selling 750 shares of non-convertible Series B Preferred Stock to Optimus Life Sciences Capital Partners, LLC under a previously announced $10 million Preferred Stock transaction. ACT also eliminated more than $10 million of indebtedness through conversions and settled more than $10 milli- on of other liabilities.
http://www.advancedcell.com
contract with the Hawai‘i Natural Energy Institute (HNEI) of the University of Hawai‘i at Manoa to sup- ply a one-megawatt ALTI-ESS energy storage system for a test of wind energy integration. The system will be installed at the Hawi wind farm on the island of Hawai‘i and connected to the Hawai‘i Electric Light Company (HELCO) utility grid. The equipment purchase and associated service contracts, valued at approximately $1.8 million dollars, require Altairna- no to build, ship, install and commission its ALTI-ESS advanced energy storage system, and provide tech- nical support and system monitoring and reporting over a period of three years. The project is expected to be operational by the third quarter of 2011.
http://www.altairnano.com
A F
or the fourth quarter of 2010, AMCOL Internatio- nal Corporation (NYSE: ACO) reports a loss attri-
butable to AMCOL shareholders of $0.30 per diluted share compared to earnings of $0.36 per diluted share in the 2009 period. However, these losses re- sult largely from unusual items recorded in the fourth
ltair Nanotechnologies, Inc. (Altairnano, NASDAQ: ALTI) had been awarded a firm
quarter of 2010. Excluding these unusual items, we generated net income attributable to AMCOL share- holders of $0.21 per diluted share as compared to the prior year amount of $0.31 per diluted share, which has also been adjusted for unusual items. Net sales increased 26.4% to $223.4 million for the quar- ter ended December 31, 2010, compared to $176.7 million for the 2009 period. Operating profit increa- sed by 11.6% over the 2009 period to $11.5 million. Foreign currency translation did not have a material impact on our comparative results for the quarter.
Long-term debt increased $29.2 million to $236.2 million during our 2010 fiscal year. Net working capital increased $45.4 million during the year to $249.1 million at December 31, 2010. The increase in working capital was due to increased sales vo- lumes.
http://www.amcol.com
SCIL (Substrate Conformal Imprint Lithography) with UV curing material. AMO has provided two key components for this development: the master for large-area nanostructures and the UV-curing nanoim- print material AMONIL. The masters, with a size up to 6inch, are fabricated at AMO by laser interference lithography and plasma etching in Silicon. They have perfect binary periodic patterns between 180 to 2.500nm. These holographic gratings are cha- racterized by absolutely seamless patterns and a low defect-density on a large area, due to a special fabri- cation technology.
http://www.amo.de
A
MO in Germany and SUSS MicroTec AG are working on the development of applications for
11-01 :: December 2010 / January 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95